content: <?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <headerData>
  <submissionType>144</submissionType>
  <filerInfo>
  <filer>
  <filerCredentials>
  <cik>0001283303</cik>
  <ccc>XXXXXXXX</ccc>
  </filerCredentials>
  </filer>
  <liveTestFlag>LIVE</liveTestFlag>
  </filerInfo>
  </headerData>
  <formData>
  <issuerInfo>
  <issuerCik>0001438533</issuerCik>
  <issuerName>Travere Therapeutics, Inc.</issuerName>
  <secFileNumber>001-36257</secFileNumber>
  <issuerAddress>
  <street1 xmlns="http://www.sec.gov/edgar/common">3611 Valley Centre Dr.</street1>
  <street2 xmlns="http://www.sec.gov/edgar/common">Suite 300</street2>
  <city xmlns="http://www.sec.gov/edgar/common">San Diego</city>
  <stateOrCountry xmlns="http://www.sec.gov/edgar/common">CA</stateOrCountry>
  <zipCode xmlns="http://www.sec.gov/edgar/common">92130</zipCode>
  </issuerAddress>
  <issuerContactPhone>888-969-7879</issuerContactPhone>
  <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Elizabeth E. Reed</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
  <relationshipsToIssuer>
  <relationshipToIssuer>Officer</relationshipToIssuer>
  </relationshipsToIssuer>
  </issuerInfo>
  <securitiesInformation>
  <securitiesClassTitle>Common</securitiesClassTitle>
  <brokerOrMarketmakerDetails>
  <name>Morgan Stanley Smith Barney</name>
  <address>
  <street1 xmlns="http://www.sec.gov/edgar/common">3 Edison Drive</street1>
  <city xmlns="http://www.sec.gov/edgar/common">Alpharetta</city>
  <stateOrCountry xmlns="http://www.sec.gov/edgar/common">GA</stateOrCountry>
  <zipCode xmlns="http://www.sec.gov/edgar/common">30005</zipCode>
  </address>
  </brokerOrMarketmakerDetails>
  <noOfUnitsSold>2174</noOfUnitsSold>
  <aggregateMarketValue>18547.85</aggregateMarketValue>
  <noOfUnitsOutstanding>75145831</noOfUnitsOutstanding>
  <approxSaleDate>02/01/2024</approxSaleDate>
  <securitiesExchangeName>NASDAQ</securitiesExchangeName>
  </securitiesInformation>
  <securitiesToBeSold>
  <securitiesClassTitle>Common</securitiesClassTitle>
  <acquiredDate>01/31/2024</acquiredDate>
  <natureOfAcquisitionTransaction>Restricted Stock Unit Vesting</natureOfAcquisitionTransaction>
  <nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
  <isGiftTransaction>N</isGiftTransaction>
  <amountOfSecuritiesAcquired>2174</amountOfSecuritiesAcquired>
  <paymentDate>01/31/2024</paymentDate>
  <natureOfPayment>Compensation</natureOfPayment>
  </securitiesToBeSold>
  <nothingToReportFlagOnSecuritiesSoldInPast3Months>N</nothingToReportFlagOnSecuritiesSoldInPast3Months>
  <securitiesSoldInPast3Months>
  <sellerDetails>
  <name>Elizabeth E. Reed</name>
  <address>
  <street1 xmlns="http://www.sec.gov/edgar/common">3611 Valley Centre Drive</street1>
  <street2 xmlns="http://www.sec.gov/edgar/common">Suite 300</street2>
  <city xmlns="http://www.sec.gov/edgar/common">San Diego</city>
  <stateOrCountry xmlns="http://www.sec.gov/edgar/common">CA</stateOrCountry>
  <zipCode xmlns="http://www.sec.gov/edgar/common">92130</zipCode>
  </address>
  </sellerDetails>
  <securitiesClassTitle>Common</securitiesClassTitle>
  <saleDate>01/23/2024</saleDate>
  <amountOfSecuritiesSold>2062</amountOfSecuritiesSold>
  <grossProceeds>18475.52</grossProceeds>
  </securitiesSoldInPast3Months>
  <securitiesSoldInPast3Months>
  <sellerDetails>
  <name>Elizabeth E. Reed</name>
  <address>
  <street1 xmlns="http://www.sec.gov/edgar/common">3611 Valley Centre Drive</street1>
  <street2 xmlns="http://www.sec.gov/edgar/common">Suite 300</street2>
  <city xmlns="http://www.sec.gov/edgar/common">San Diego</city>
  <stateOrCountry xmlns="http://www.sec.gov/edgar/common">CA</stateOrCountry>
  <zipCode xmlns="http://www.sec.gov/edgar/common">92130</zipCode>
  </address>
  </sellerDetails>
  <securitiesClassTitle>Common</securitiesClassTitle>
  <saleDate>02/01/2024</saleDate>
  <amountOfSecuritiesSold>2590</amountOfSecuritiesSold>
  <grossProceeds>22947.40</grossProceeds>
  </securitiesSoldInPast3Months>
  <remarks>Represents the number of shares required to be sold by the Reporting Person to cover the tax withholding obligation in connection with the settlement of vested restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the Reporting Person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the Reporting Person.</remarks>
  <noticeSignature>
  <noticeDate>02/01/2024</noticeDate>
  <signature>/s/ Elizabeth E. Reed</signature>
  </noticeSignature>
  </formData>
  </edgarSubmission>
metadata_documents: [{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 4621}]
text: 144
  0001283303
  XXXXXXXX
  LIVE
  0001438533
  Travere Therapeutics, Inc.
  001-36257
  3611 Valley Centre Dr.
  Suite 300
  San Diego
  CA
  92130
  888-969-7879
  Elizabeth E. Reed
  Officer
  Common
  Morgan Stanley Smith Barney
  3 Edison Drive
  Alpharetta
  GA
  30005
  2174
  18547.85
  75145831
  02/01/2024
  NASDAQ
  Common
  01/31/2024
  Restricted Stock Unit Vesting
  Issuer
  N
  2174
  01/31/2024
  Compensation
  N
  Elizabeth E. Reed
  3611 Valley Centre Drive
  Suite 300
  San Diego
  CA
  92130
  Common
  01/23/2024
  2062
  18475.52
  Elizabeth E. Reed
  3611 Valley Centre Drive
  Suite 300
  San Diego
  CA
  92130
  Common
  02/01/2024
  2590
  22947.40
  Represents the number of shares required to be sold by the Reporting Person to cover the tax withholding obligation in connection with the settlement of vested restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the Reporting Person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the Reporting Person.
  02/01/2024
  /s/ Elizabeth E. Reed